photo of Dr Declan Turner

Dr Declan Turner

Dr Declan Turner

Details

Role Postdoctoral Researcher
Research area Stem Cell Medicine
Dr Declan Turner is a postdoctoral researcher at the Murdoch Children’s Research Institute. He works with Dr Rhiannon Werder to study respiratory virus infections using induced pluripotent stem cell-derived lung models as part of the ReNEW program.

Declan completed a Bachelor of Science from Monash University in 2016, majoring in microbiology and immunology. As an undergraduate, he was awarded a UROP scholarship to investigate microRNA regulation of protein aggregation in a C. elegans model of Huntington’s Disease. He went on to complete an honours project at the Monash Biomedicine Discovery Institute in 2018 under the supervision of Dr Rommel Mathias investigating replication mechanisms of human cytomegalovirus (HCMV), an important pathogen of the immunocompromised. In 2019, he was awarded an Australian Government RTP scholarship to continue his research on HCMV where he specifically focussed on the molecular mechanisms driving virion assembly, envelopment and egress from both host and viral perspectives, using classical virology and systems biology approaches. In 2022, he was awarded the CSL Prize for this work which recognises the top PhD thesis in the Monash Microbiology Department.
Dr Declan Turner is a postdoctoral researcher at the Murdoch Children’s Research Institute. He works with Dr Rhiannon Werder to study respiratory virus infections using induced pluripotent stem cell-derived lung models as part of the ReNEW program.
Dr Declan Turner is a postdoctoral researcher at the Murdoch Children’s Research Institute. He works with Dr Rhiannon Werder to study respiratory virus infections using induced pluripotent stem cell-derived lung models as part of the ReNEW program.

Declan completed a Bachelor of Science from Monash University in 2016, majoring in microbiology and immunology. As an undergraduate, he was awarded a UROP scholarship to investigate microRNA regulation of protein aggregation in a C. elegans model of Huntington’s Disease. He went on to complete an honours project at the Monash Biomedicine Discovery Institute in 2018 under the supervision of Dr Rommel Mathias investigating replication mechanisms of human cytomegalovirus (HCMV), an important pathogen of the immunocompromised. In 2019, he was awarded an Australian Government RTP scholarship to continue his research on HCMV where he specifically focussed on the molecular mechanisms driving virion assembly, envelopment and egress from both host and viral perspectives, using classical virology and systems biology approaches. In 2022, he was awarded the CSL Prize for this work which recognises the top PhD thesis in the Monash Microbiology Department.

Top Publications

  • Turner, DL, Fritzlar, S, Sadeghipour, S, Barugahare, AA, Russ, BE, Turner, SJ, Mathias, RA. UL49 is an essential subunit of the viral pre-initiation complex that regulates human cytomegalovirus gene transcription. iScience 25(10) : 105168 2022
    view publication
  • Turner, DL, Templin, RM, Barugahare, AA, Russ, BE, Turner, SJ, Ramm, G, Mathias, RA. UL34 Deletion Restricts Human Cytomegalovirus Capsid Formation and Maturation.. Int J Mol Sci 23(10) : 2022
    view publication
  • Turner, DL, Mathias, RA. The human cytomegalovirus decathlon: Ten critical replication events provide opportunities for restriction.. Front Cell Dev Biol 10: 1053139 2022
    view publication
  • Turner, DL, Korneev, DV, Purdy, JG, de Marco, A, Mathias, RA. The host exosome pathway underpins biogenesis of the human cytomegalovirus virion.. Elife 9: 2020
    view publication

Career information